Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance

It has been frequently stressed that improved methods are needed to monitor the fast spread of drug-resistant Plasmodium falciparum parasites in endemic areas. We recently developed a colourimetric microtest, double-site enzyme-linked lactate dehydrogenase enzyme immunodetection assay (DELI), to ass...

Full description

Saved in:
Bibliographic Details
Published inTransactions of the Royal Society of Tropical Medicine and Hygiene Vol. 95; no. 1; pp. 100 - 103
Main Authors Moreno, A., Brasseur, P., Cuzin-Ouattara, N., Blanc, C., Druilhe, P.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 2001
Royal Society of Tropical Medicine and Hygiene
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It has been frequently stressed that improved methods are needed to monitor the fast spread of drug-resistant Plasmodium falciparum parasites in endemic areas. We recently developed a colourimetric microtest, double-site enzyme-linked lactate dehydrogenase enzyme immunodetection assay (DELI), to assess drug resistance in vitro. This method, which proved highly effective under laboratory conditions, was evaluated under field conditions in 2 African areas (in Senegal and Burkina Faso) in 1997 and 1998, respectively. The sensitivities of isolates from symptomatic ( n = 50) and asymptomatic individuals ( n = 26) infected with P. falciparum were assessed in parallel by the new DELI-microtest and the isotopic-microtest. IC50 values of the isolates determined for chloroquine, quinine, amodiaquine and mefloquine were well correlated ( r = 0 · 79, P < 0 · 001). The proportions of sensitive and resistant isolates determined using the 2 methods were similar. The DELI-microtest proved to be faster to implement than the isotopic-microtest, easier to perform, and did not require sophisticated equipment. Moreover, a larger number of isolates can be tested since parasitaemias as low as 0 · 005% could be reliably measured with the DELI-microtest. These initial field studies thus support the value of the DELI-microtest for large-scale drug-sensitivity monitoring.
Bibliography:ark:/67375/HXZ-0X6FGGSS-4
istex:CB305B6FAA0D0B8B04F3B2F5B875814058AC20B7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0035-9203
1878-3503
DOI:10.1016/S0035-9203(01)90351-7